New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 11, 2013
16:08 EDTCRMDCorMedix files to sell 3.78M shares of common stock for holders
News For CRMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
08:03 EDTCRMDCorMedix notified of compliance with NYSE requirements
The NYSE MKT notified CorMedix that the company has regained compliance with the NYSE MKT listing requirements since the Company as of February 26, 2015 qualified for the market capitalization exception in Section 1003a of the NYSE MKT Company Guide.
08:03 EDTCRMDCorMedix extends expiration date of certain warrants
Subscribe for More Information
08:03 EDTCRMDCorMedix engages Evercore to explore strategic alternatives
CorMedix announced that it has retained investment bank Evercore as financial advisor to explore strategic alternatives, in order to accelerate the global development of Neutrolin Catheter Lock Solution and maximize shareholder value. CEO Randy Milby commented, "Based on our ongoing belief in the value and clinical potential of Neutrolin® as an important product to address a significant medical need, the CorMedix Board and management has retained Evercore to evaluate and identify strategic alternatives aimed to accelerate the product's global development and commercialization. We believe Evercore's premier reputation, track record, and industry expertise will help us to maximize the value of Neutrolin® more efficiently."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use